Skip to main content

Type 1 Diabetes News

Type 1 Diabetes is a chronic condition in which your body loses the ability to produce insulin, which is necessary for most cells to convert food into energy and regulate blood sugar levels. 

We recently had the privilege of attending Medtronic’s 2nd Annual Diabetes Advocate Forum, held at the company’s headquarters in Northridge, CA, on March 30. The event...
We last wrote about Type 1 University (T1U) in our test drive in diaTribe #29 – at the time, we were quite impressed after attending two of Gary Scheiner’s advanced...
We are encouraged to report that the FDA has approved Levemir for use in pregnant women with type 1, type 2, or gestational diabetes. Levemir is a long acting, or “basal...
Cutting through the information clutter.
Our highs and lows while trying out Symlin.
Caps off to this intensive manager, Phil Southerland.
Irl B. Hirsch, MD, an internationally-recognized diabetes expert and former ADA Clinician of the Year, is a professor of medicine at the University of Washington School...
An African-American who has spent his entire career in corporate America, Donald is now the president and chief executive officer of a non-profit organization that -...
Talking with two diabetes titans, Dr. Irl Hirsch, endocrinologist extraordinaire, and Arnold Donald, striking new head of the JDRF.
A story of bigotry on a radio show.
Feel the excitement.
On April 9, the FDA announced that it had extended the decision date for Vivus’ obesity medication Qnexa by three months to July 17. The agency postponed its approval...
Dr. Diana Guthrie, winner of the AADE Living Legend Award, on controlled breathing and supplements for people with diabetes…
Kelly reflects on the inspirational work of diabetes educators and how ancient practices are blending with modern science.
With educator extraordinaire Davida Kruger
Cutting through the information clutter in this issue.
Stem cells, George Bush, and a parent's dream.
Trying out DexCom's continuous glucose monitor.
Drumroll, please.
July 15, 2015 In another disappointing turn, Diamyd Medical announced in late June that it was suspending a phase 3 trial for its GAD65 vaccine Diamyd. The US-based...

Pages